Components:
Method of action:
Treatment option:
Gonorrhea, Infection, Middle Ear Infection, Fever, Meningitis, Abscess, COPD,Acute, Pneumonia, Pregnancy, Asymptomatic bacteriuria, Sinus Infection, Lyme Disease, Joint Infection, Dental, Typhoid, Tonsillitis, Pharyngitis, Dental Abscess, Helicobacter Pylori, Chronic Middle Ear Infection, Cellulite, Bronchitis, Cystitis, Endocarditis, Enteritis, Community Acquired Pneumonia
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 26.06.2023
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Special precautions for disposal and other handling
Check cap seal is intact before use.
Invert and shake bottle to loosen powder.
To prepare add 64ml of potable water and shake until all contents are dispersed
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
Marketing authorisation holder
Athlone Laboratories Limited
Ballymurray
Co. Roscommon
Ireland
Marketing authorisation number(s)
PL 06453/0021
Date of first authorisation/renewal of the authorisation
First Authorisation: 17/10/1990
Renewal: 29/01/2003
Date of revision of the text
19 October 2017
ATC - Anatomical and therapeutic chemical classification
- R52.1 – Chronic intractable pain
- R52.2 – Other chronic pain
- R52.9 – Unspecified pain
